To investigate if this effect on p53 binding is observed in any cancer-derived ALT cells, we assayed U2OS (Supplementary Fig. 5a, b) and GM847 and VA13 (Supplementary Fig. 5c, d), known to have WT p53 protein and an ATRX null background29,30. The gene discussed is GPT; the disease is cancer.